aluates Reports

$ 0.0

Automative

Global Tumor-Infiltrating Lymphocyte Therapy Market Research Report 2024

Published Date: October 2024

Report Code: QYRE-Auto-22Y18315

BUY CHAPTERS

Global Tumor-Infiltrating Lymphocyte Therapy Market Research Report 2024

Code: QYRE-Auto-22Y18315

Report

October 2024

Pages:81

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Iovance Biotherapeutics

Moffitt Cancer Center

Essen Biotech

Turnstone Biologics

Obsidian Therapeutics

Hervor Therapeutics

Intima Bioscience

Instil Bio

Shanghai Juncell Therapeutics

Suzhou BlueHorse Therapeutics

Grit Biotechnology

TCRCure Biopharma

BioSyngen

Sino-Cell Biomed

Tumor-Infiltrating Lymphocyte Therapy Market

Tumor-Infiltrating Lymphocyte therapy is a form of adoptive cell therapy used in cancer treatment that harnesses the patient’s own immune cells to fight tumors. TILs are a type of immune cell that naturally penetrate tumor tissues. In TIL therapy, these lymphocytes are extracted from the patient's tumor, expanded in large numbers in a laboratory, and then reintroduced into the patient after the tumor has been reduced or suppressed, typically following lymphodepleting chemotherapy.TIL therapy has shown promise particularly in the treatment of melanoma and other solid tumors.

The global Tumor-Infiltrating Lymphocyte Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.

North American market for Tumor-Infiltrating Lymphocyte Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Tumor-Infiltrating Lymphocyte Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Tumor-Infiltrating Lymphocyte Therapy in Melanoma is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Tumor-Infiltrating Lymphocyte Therapy include Iovance Biotherapeutics, Moffitt Cancer Center, Essen Biotech, Turnstone Biologics, Obsidian Therapeutics, Hervor Therapeutics, Intima Bioscience, Instil Bio, Shanghai Juncell Therapeutics, Suzhou BlueHorse Therapeutics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Tumor-Infiltrating Lymphocyte Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tumor-Infiltrating Lymphocyte Therapy.

The Tumor-Infiltrating Lymphocyte Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tumor-Infiltrating Lymphocyte Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Tumor-Infiltrating Lymphocyte Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Tumor-Infiltrating Lymphocyte Therapy Market Report

Report Metric	Details
Report Name	Tumor-Infiltrating Lymphocyte Therapy Market
Segment by Type	Combined with IL-2 Not Combined with IL-2
Segment by Application	Melanoma Cervical Cancer Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Iovance Biotherapeutics, Moffitt Cancer Center, Essen Biotech, Turnstone Biologics, Obsidian Therapeutics, Hervor Therapeutics, Intima Bioscience, Instil Bio, Shanghai Juncell Therapeutics, Suzhou BlueHorse Therapeutics, Grit Biotechnology, TCRCure Biopharma, BioSyngen, Sino-Cell Biomed
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tumor-Infiltrating Lymphocyte Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Tumor-Infiltrating Lymphocyte Therapy Market report?

Ans: The main players in the Tumor-Infiltrating Lymphocyte Therapy Market are Iovance Biotherapeutics, Moffitt Cancer Center, Essen Biotech, Turnstone Biologics, Obsidian Therapeutics, Hervor Therapeutics, Intima Bioscience, Instil Bio, Shanghai Juncell Therapeutics, Suzhou BlueHorse Therapeutics, Grit Biotechnology, TCRCure Biopharma, BioSyngen, Sino-Cell Biomed

What are the Application segmentation covered in the Tumor-Infiltrating Lymphocyte Therapy Market report?

Ans: The Applications covered in the Tumor-Infiltrating Lymphocyte Therapy Market report are Melanoma, Cervical Cancer, Others

What are the Type segmentation covered in the Tumor-Infiltrating Lymphocyte Therapy Market report?

Ans: The Types covered in the Tumor-Infiltrating Lymphocyte Therapy Market report are Combined with IL-2, Not Combined with IL-2

Recommended Reports

Immunotherapy Markets

Cell Therapy Markets

Cancer & Lymphoma Therapy

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Tumor-Infiltrating Lymphocyte Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Combined with IL-2

1.2.3 Not Combined with IL-2

1.3 Market by Application

1.3.1 Global Tumor-Infiltrating Lymphocyte Therapy Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Melanoma

1.3.3 Cervical Cancer

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Tumor-Infiltrating Lymphocyte Therapy Market Perspective (2019-2030)

2.2 Global Tumor-Infiltrating Lymphocyte Therapy Growth Trends by Region

2.2.1 Global Tumor-Infiltrating Lymphocyte Therapy Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Tumor-Infiltrating Lymphocyte Therapy Historic Market Size by Region (2019-2024)

2.2.3 Tumor-Infiltrating Lymphocyte Therapy Forecasted Market Size by Region (2025-2030)

2.3 Tumor-Infiltrating Lymphocyte Therapy Market Dynamics

2.3.1 Tumor-Infiltrating Lymphocyte Therapy Industry Trends

2.3.2 Tumor-Infiltrating Lymphocyte Therapy Market Drivers

2.3.3 Tumor-Infiltrating Lymphocyte Therapy Market Challenges

2.3.4 Tumor-Infiltrating Lymphocyte Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Tumor-Infiltrating Lymphocyte Therapy Players by Revenue

3.1.1 Global Top Tumor-Infiltrating Lymphocyte Therapy Players by Revenue (2019-2024)

3.1.2 Global Tumor-Infiltrating Lymphocyte Therapy Revenue Market Share by Players (2019-2024)

3.2 Global Tumor-Infiltrating Lymphocyte Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Tumor-Infiltrating Lymphocyte Therapy Revenue

3.4 Global Tumor-Infiltrating Lymphocyte Therapy Market Concentration Ratio

3.4.1 Global Tumor-Infiltrating Lymphocyte Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Tumor-Infiltrating Lymphocyte Therapy Revenue in 2023

3.5 Global Key Players of Tumor-Infiltrating Lymphocyte Therapy Head office and Area Served

3.6 Global Key Players of Tumor-Infiltrating Lymphocyte Therapy, Product and Application

3.7 Global Key Players of Tumor-Infiltrating Lymphocyte Therapy, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Tumor-Infiltrating Lymphocyte Therapy Breakdown Data by Type

4.1 Global Tumor-Infiltrating Lymphocyte Therapy Historic Market Size by Type (2019-2024)

4.2 Global Tumor-Infiltrating Lymphocyte Therapy Forecasted Market Size by Type (2025-2030)

5 Tumor-Infiltrating Lymphocyte Therapy Breakdown Data by Application

5.1 Global Tumor-Infiltrating Lymphocyte Therapy Historic Market Size by Application (2019-2024)

5.2 Global Tumor-Infiltrating Lymphocyte Therapy Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Tumor-Infiltrating Lymphocyte Therapy Market Size (2019-2030)

6.2 North America Tumor-Infiltrating Lymphocyte Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2019-2024)

6.4 North America Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Tumor-Infiltrating Lymphocyte Therapy Market Size (2019-2030)

7.2 Europe Tumor-Infiltrating Lymphocyte Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2019-2024)

7.4 Europe Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Tumor-Infiltrating Lymphocyte Therapy Market Size (2019-2030)

8.2 Asia-Pacific Tumor-Infiltrating Lymphocyte Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Tumor-Infiltrating Lymphocyte Therapy Market Size by Region (2019-2024)

8.4 Asia-Pacific Tumor-Infiltrating Lymphocyte Therapy Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Tumor-Infiltrating Lymphocyte Therapy Market Size (2019-2030)

9.2 Latin America Tumor-Infiltrating Lymphocyte Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2019-2024)

9.4 Latin America Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Market Size (2019-2030)

10.2 Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2019-2024)

10.4 Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Iovance Biotherapeutics

11.1.1 Iovance Biotherapeutics Company Details

11.1.2 Iovance Biotherapeutics Business Overview

11.1.3 Iovance Biotherapeutics Tumor-Infiltrating Lymphocyte Therapy Introduction

11.1.4 Iovance Biotherapeutics Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2019-2024)

11.1.5 Iovance Biotherapeutics Recent Development

11.2 Moffitt Cancer Center

11.2.1 Moffitt Cancer Center Company Details

11.2.2 Moffitt Cancer Center Business Overview

11.2.3 Moffitt Cancer Center Tumor-Infiltrating Lymphocyte Therapy Introduction

11.2.4 Moffitt Cancer Center Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2019-2024)

11.2.5 Moffitt Cancer Center Recent Development

11.3 Essen Biotech

11.3.1 Essen Biotech Company Details

11.3.2 Essen Biotech Business Overview

11.3.3 Essen Biotech Tumor-Infiltrating Lymphocyte Therapy Introduction

11.3.4 Essen Biotech Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2019-2024)

11.3.5 Essen Biotech Recent Development

11.4 Turnstone Biologics

11.4.1 Turnstone Biologics Company Details

11.4.2 Turnstone Biologics Business Overview

11.4.3 Turnstone Biologics Tumor-Infiltrating Lymphocyte Therapy Introduction

11.4.4 Turnstone Biologics Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2019-2024)

11.4.5 Turnstone Biologics Recent Development

11.5 Obsidian Therapeutics

11.5.1 Obsidian Therapeutics Company Details

11.5.2 Obsidian Therapeutics Business Overview

11.5.3 Obsidian Therapeutics Tumor-Infiltrating Lymphocyte Therapy Introduction

11.5.4 Obsidian Therapeutics Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2019-2024)

11.5.5 Obsidian Therapeutics Recent Development

11.6 Hervor Therapeutics

11.6.1 Hervor Therapeutics Company Details

11.6.2 Hervor Therapeutics Business Overview

11.6.3 Hervor Therapeutics Tumor-Infiltrating Lymphocyte Therapy Introduction

11.6.4 Hervor Therapeutics Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2019-2024)

11.6.5 Hervor Therapeutics Recent Development

11.7 Intima Bioscience

11.7.1 Intima Bioscience Company Details

11.7.2 Intima Bioscience Business Overview

11.7.3 Intima Bioscience Tumor-Infiltrating Lymphocyte Therapy Introduction

11.7.4 Intima Bioscience Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2019-2024)

11.7.5 Intima Bioscience Recent Development

11.8 Instil Bio

11.8.1 Instil Bio Company Details

11.8.2 Instil Bio Business Overview

11.8.3 Instil Bio Tumor-Infiltrating Lymphocyte Therapy Introduction

11.8.4 Instil Bio Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2019-2024)

11.8.5 Instil Bio Recent Development

11.9 Shanghai Juncell Therapeutics

11.9.1 Shanghai Juncell Therapeutics Company Details

11.9.2 Shanghai Juncell Therapeutics Business Overview

11.9.3 Shanghai Juncell Therapeutics Tumor-Infiltrating Lymphocyte Therapy Introduction

11.9.4 Shanghai Juncell Therapeutics Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2019-2024)

11.9.5 Shanghai Juncell Therapeutics Recent Development

11.10 Suzhou BlueHorse Therapeutics

11.10.1 Suzhou BlueHorse Therapeutics Company Details

11.10.2 Suzhou BlueHorse Therapeutics Business Overview

11.10.3 Suzhou BlueHorse Therapeutics Tumor-Infiltrating Lymphocyte Therapy Introduction

11.10.4 Suzhou BlueHorse Therapeutics Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2019-2024)

11.10.5 Suzhou BlueHorse Therapeutics Recent Development

11.11 Grit Biotechnology

11.11.1 Grit Biotechnology Company Details

11.11.2 Grit Biotechnology Business Overview

11.11.3 Grit Biotechnology Tumor-Infiltrating Lymphocyte Therapy Introduction

11.11.4 Grit Biotechnology Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2019-2024)

11.11.5 Grit Biotechnology Recent Development

11.12 TCRCure Biopharma

11.12.1 TCRCure Biopharma Company Details

11.12.2 TCRCure Biopharma Business Overview

11.12.3 TCRCure Biopharma Tumor-Infiltrating Lymphocyte Therapy Introduction

11.12.4 TCRCure Biopharma Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2019-2024)

11.12.5 TCRCure Biopharma Recent Development

11.13 BioSyngen

11.13.1 BioSyngen Company Details

11.13.2 BioSyngen Business Overview

11.13.3 BioSyngen Tumor-Infiltrating Lymphocyte Therapy Introduction

11.13.4 BioSyngen Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2019-2024)

11.13.5 BioSyngen Recent Development

11.14 Sino-Cell Biomed

11.14.1 Sino-Cell Biomed Company Details

11.14.2 Sino-Cell Biomed Business Overview

11.14.3 Sino-Cell Biomed Tumor-Infiltrating Lymphocyte Therapy Introduction

11.14.4 Sino-Cell Biomed Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2019-2024)

11.14.5 Sino-Cell Biomed Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Iovance Biotherapeutics

Moffitt Cancer Center

Essen Biotech

Turnstone Biologics

Obsidian Therapeutics

Hervor Therapeutics

Intima Bioscience

Instil Bio

Shanghai Juncell Therapeutics

Suzhou BlueHorse Therapeutics

Grit Biotechnology

TCRCure Biopharma

BioSyngen

Sino-Cell Biomed

List of Tables

Table 1. Global Tumor-Infiltrating Lymphocyte Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Combined with IL-2

Table 3. Key Players of Not Combined with IL-2

Table 4. Global Tumor-Infiltrating Lymphocyte Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Tumor-Infiltrating Lymphocyte Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Tumor-Infiltrating Lymphocyte Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Tumor-Infiltrating Lymphocyte Therapy Market Share by Region (2019-2024)

Table 8. Global Tumor-Infiltrating Lymphocyte Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Tumor-Infiltrating Lymphocyte Therapy Market Share by Region (2025-2030)

Table 10. Tumor-Infiltrating Lymphocyte Therapy Market Trends

Table 11. Tumor-Infiltrating Lymphocyte Therapy Market Drivers

Table 12. Tumor-Infiltrating Lymphocyte Therapy Market Challenges

Table 13. Tumor-Infiltrating Lymphocyte Therapy Market Restraints

Table 14. Global Tumor-Infiltrating Lymphocyte Therapy Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Tumor-Infiltrating Lymphocyte Therapy Market Share by Players (2019-2024)

Table 16. Global Top Tumor-Infiltrating Lymphocyte Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor-Infiltrating Lymphocyte Therapy as of 2023)

Table 17. Ranking of Global Top Tumor-Infiltrating Lymphocyte Therapy Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Tumor-Infiltrating Lymphocyte Therapy Revenue (CR5 and HHI) & (2019-2024)

Table 19. Global Key Players of Tumor-Infiltrating Lymphocyte Therapy, Headquarters and Area Served

Table 20. Global Key Players of Tumor-Infiltrating Lymphocyte Therapy, Product and Application

Table 21. Global Key Players of Tumor-Infiltrating Lymphocyte Therapy, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Tumor-Infiltrating Lymphocyte Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Tumor-Infiltrating Lymphocyte Therapy Revenue Market Share by Type (2019-2024)

Table 25. Global Tumor-Infiltrating Lymphocyte Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Tumor-Infiltrating Lymphocyte Therapy Revenue Market Share by Type (2025-2030)

Table 27. Global Tumor-Infiltrating Lymphocyte Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Tumor-Infiltrating Lymphocyte Therapy Revenue Market Share by Application (2019-2024)

Table 29. Global Tumor-Infiltrating Lymphocyte Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Tumor-Infiltrating Lymphocyte Therapy Revenue Market Share by Application (2025-2030)

Table 31. North America Tumor-Infiltrating Lymphocyte Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Tumor-Infiltrating Lymphocyte Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Tumor-Infiltrating Lymphocyte Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Tumor-Infiltrating Lymphocyte Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Tumor-Infiltrating Lymphocyte Therapy Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Tumor-Infiltrating Lymphocyte Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 46. Iovance Biotherapeutics Company Details

Table 47. Iovance Biotherapeutics Business Overview

Table 48. Iovance Biotherapeutics Tumor-Infiltrating Lymphocyte Therapy Product

Table 49. Iovance Biotherapeutics Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2019-2024) & (US$ Million)

Table 50. Iovance Biotherapeutics Recent Development

Table 51. Moffitt Cancer Center Company Details

Table 52. Moffitt Cancer Center Business Overview

Table 53. Moffitt Cancer Center Tumor-Infiltrating Lymphocyte Therapy Product

Table 54. Moffitt Cancer Center Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2019-2024) & (US$ Million)

Table 55. Moffitt Cancer Center Recent Development

Table 56. Essen Biotech Company Details

Table 57. Essen Biotech Business Overview

Table 58. Essen Biotech Tumor-Infiltrating Lymphocyte Therapy Product

Table 59. Essen Biotech Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2019-2024) & (US$ Million)

Table 60. Essen Biotech Recent Development

Table 61. Turnstone Biologics Company Details

Table 62. Turnstone Biologics Business Overview

Table 63. Turnstone Biologics Tumor-Infiltrating Lymphocyte Therapy Product

Table 64. Turnstone Biologics Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2019-2024) & (US$ Million)

Table 65. Turnstone Biologics Recent Development

Table 66. Obsidian Therapeutics Company Details

Table 67. Obsidian Therapeutics Business Overview

Table 68. Obsidian Therapeutics Tumor-Infiltrating Lymphocyte Therapy Product

Table 69. Obsidian Therapeutics Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2019-2024) & (US$ Million)

Table 70. Obsidian Therapeutics Recent Development

Table 71. Hervor Therapeutics Company Details

Table 72. Hervor Therapeutics Business Overview

Table 73. Hervor Therapeutics Tumor-Infiltrating Lymphocyte Therapy Product

Table 74. Hervor Therapeutics Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2019-2024) & (US$ Million)

Table 75. Hervor Therapeutics Recent Development

Table 76. Intima Bioscience Company Details

Table 77. Intima Bioscience Business Overview

Table 78. Intima Bioscience Tumor-Infiltrating Lymphocyte Therapy Product

Table 79. Intima Bioscience Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2019-2024) & (US$ Million)

Table 80. Intima Bioscience Recent Development

Table 81. Instil Bio Company Details

Table 82. Instil Bio Business Overview

Table 83. Instil Bio Tumor-Infiltrating Lymphocyte Therapy Product

Table 84. Instil Bio Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2019-2024) & (US$ Million)

Table 85. Instil Bio Recent Development

Table 86. Shanghai Juncell Therapeutics Company Details

Table 87. Shanghai Juncell Therapeutics Business Overview

Table 88. Shanghai Juncell Therapeutics Tumor-Infiltrating Lymphocyte Therapy Product

Table 89. Shanghai Juncell Therapeutics Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2019-2024) & (US$ Million)

Table 90. Shanghai Juncell Therapeutics Recent Development

Table 91. Suzhou BlueHorse Therapeutics Company Details

Table 92. Suzhou BlueHorse Therapeutics Business Overview

Table 93. Suzhou BlueHorse Therapeutics Tumor-Infiltrating Lymphocyte Therapy Product

Table 94. Suzhou BlueHorse Therapeutics Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2019-2024) & (US$ Million)

Table 95. Suzhou BlueHorse Therapeutics Recent Development

Table 96. Grit Biotechnology Company Details

Table 97. Grit Biotechnology Business Overview

Table 98. Grit Biotechnology Tumor-Infiltrating Lymphocyte Therapy Product

Table 99. Grit Biotechnology Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2019-2024) & (US$ Million)

Table 100. Grit Biotechnology Recent Development

Table 101. TCRCure Biopharma Company Details

Table 102. TCRCure Biopharma Business Overview

Table 103. TCRCure Biopharma Tumor-Infiltrating Lymphocyte Therapy Product

Table 104. TCRCure Biopharma Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2019-2024) & (US$ Million)

Table 105. TCRCure Biopharma Recent Development

Table 106. BioSyngen Company Details

Table 107. BioSyngen Business Overview

Table 108. BioSyngen Tumor-Infiltrating Lymphocyte Therapy Product

Table 109. BioSyngen Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2019-2024) & (US$ Million)

Table 110. BioSyngen Recent Development

Table 111. Sino-Cell Biomed Company Details

Table 112. Sino-Cell Biomed Business Overview

Table 113. Sino-Cell Biomed Tumor-Infiltrating Lymphocyte Therapy Product

Table 114. Sino-Cell Biomed Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2019-2024) & (US$ Million)

Table 115. Sino-Cell Biomed Recent Development

Table 116. Research Programs/Design for This Report

Table 117. Key Data Information from Secondary Sources

Table 118. Key Data Information from Primary Sources

Table 119. Authors List of This Report

List of Figures

Figure 1. Tumor-Infiltrating Lymphocyte Therapy Picture

Figure 2. Global Tumor-Infiltrating Lymphocyte Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Tumor-Infiltrating Lymphocyte Therapy Market Share by Type: 2023 VS 2030

Figure 4. Combined with IL-2 Features

Figure 5. Not Combined with IL-2 Features

Figure 6. Global Tumor-Infiltrating Lymphocyte Therapy Market Size by Application (2024-2030) & (US$ Million)

Figure 7. Global Tumor-Infiltrating Lymphocyte Therapy Market Share by Application: 2023 VS 2030

Figure 8. Melanoma Case Studies

Figure 9. Cervical Cancer Case Studies

Figure 10. Others Case Studies

Figure 11. Tumor-Infiltrating Lymphocyte Therapy Report Years Considered

Figure 12. Global Tumor-Infiltrating Lymphocyte Therapy Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Tumor-Infiltrating Lymphocyte Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Tumor-Infiltrating Lymphocyte Therapy Market Share by Region: 2023 VS 2030

Figure 15. Global Tumor-Infiltrating Lymphocyte Therapy Market Share by Players in 2023

Figure 16. Global Top Tumor-Infiltrating Lymphocyte Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor-Infiltrating Lymphocyte Therapy as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Tumor-Infiltrating Lymphocyte Therapy Revenue in 2023

Figure 18. North America Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Tumor-Infiltrating Lymphocyte Therapy Market Share by Country (2019-2030)

Figure 20. United States Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Tumor-Infiltrating Lymphocyte Therapy Market Share by Country (2019-2030)

Figure 24. Germany Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. France Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. U.K. Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Italy Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Russia Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Nordic Countries Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Tumor-Infiltrating Lymphocyte Therapy Market Share by Region (2019-2030)

Figure 32. China Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Japan Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. South Korea Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Southeast Asia Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. India Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Australia Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Tumor-Infiltrating Lymphocyte Therapy Market Share by Country (2019-2030)

Figure 40. Mexico Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Brazil Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Market Share by Country (2019-2030)

Figure 44. Turkey Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Saudi Arabia Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. UAE Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Iovance Biotherapeutics Revenue Growth Rate in Tumor-Infiltrating Lymphocyte Therapy Business (2019-2024)

Figure 48. Moffitt Cancer Center Revenue Growth Rate in Tumor-Infiltrating Lymphocyte Therapy Business (2019-2024)

Figure 49. Essen Biotech Revenue Growth Rate in Tumor-Infiltrating Lymphocyte Therapy Business (2019-2024)

Figure 50. Turnstone Biologics Revenue Growth Rate in Tumor-Infiltrating Lymphocyte Therapy Business (2019-2024)

Figure 51. Obsidian Therapeutics Revenue Growth Rate in Tumor-Infiltrating Lymphocyte Therapy Business (2019-2024)

Figure 52. Hervor Therapeutics Revenue Growth Rate in Tumor-Infiltrating Lymphocyte Therapy Business (2019-2024)

Figure 53. Intima Bioscience Revenue Growth Rate in Tumor-Infiltrating Lymphocyte Therapy Business (2019-2024)

Figure 54. Instil Bio Revenue Growth Rate in Tumor-Infiltrating Lymphocyte Therapy Business (2019-2024)

Figure 55. Shanghai Juncell Therapeutics Revenue Growth Rate in Tumor-Infiltrating Lymphocyte Therapy Business (2019-2024)

Figure 56. Suzhou BlueHorse Therapeutics Revenue Growth Rate in Tumor-Infiltrating Lymphocyte Therapy Business (2019-2024)

Figure 57. Grit Biotechnology Revenue Growth Rate in Tumor-Infiltrating Lymphocyte Therapy Business (2019-2024)

Figure 58. TCRCure Biopharma Revenue Growth Rate in Tumor-Infiltrating Lymphocyte Therapy Business (2019-2024)

Figure 59. BioSyngen Revenue Growth Rate in Tumor-Infiltrating Lymphocyte Therapy Business (2019-2024)

Figure 60. Sino-Cell Biomed Revenue Growth Rate in Tumor-Infiltrating Lymphocyte Therapy Business (2019-2024)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Tumor Infiltrating Lymphocyte TIL Market Research Report 2024

Global CAR T Cell Immunotherapy Market Insights Forecast to 2030

Global TCR T Cellular Immunotherapy Market Research Report 2024

Global T Cell Immunotherapy Market Research Report 2025

Global Immunosuppressants in Cancer Therapy Market Research Report 2024

Global Adoptive Cell Therapy Market Insights Forecast to 2030

Global Cancer Immunosuppressant Treatment Market Research Report 2024

Global Cancer Immuno Personalized Medicine Market Research Report 2024

Global Tumor Immune Cell Therapy Market Research Report 2024

Global Cancer Immunotherapy Drugs Market Research Report 2024

Global Cell Immunotherapy Platform Market Research Report 2024

Global Immunotherapy Drugs Market Research Report 2024

Global CAR T cell Therapy Drug Market Research Report 2025

CAR T Cellular Immunotherapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global CAR T Cell Therapy Agents Market Research Report 2025

Global Immunocell Therapy Market Insights Forecast to 2030

Global Drug based on CAR T Cell Market Research Report 2025

Global CAR T Cell Therapy Market Research Report 2025

Global Immuno Cell Therapy Market Research Report 2024

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-28I6901

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22R9736

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29A2598

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions